DOTA Conjugated JM#21 derivative 7

SKU: orb2563683

Description

This research compound, Ligand-7, is a DOTA-conjugated CXCR4-targeting peptide derivative. When radiolabeled with ¹⁷⁷Lu, it forms a targeted radioligand with high tumor specificity and low non-target organ uptake in biodistribution studies, making it suitable for oncology and molecular imaging research.

Research Area

Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery

Key Properties

• Target: CXCR
• CAS Number: 3033865-40-3
• MW: 1471.75
• Formula: C₆₆H₁₁₄N₂₂O₁₆
• SMILES: C([C@H](NC([C@@H](NC([C@@H](NC([C@H]([C@H](CC)C)N)=O)CC(C)C)=O)CCCNC(=N)N)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCCNC(CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)=O)C(N)=O)=O)CCCCN)=O)CCCNC(=N)N)=O)CO)=O)C=2C=3C(NC2)=CC=CC3

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

172653492